MUSC’s pipeline programs build the skills of underrepresented students and prepare them for careers in health care and medical research.

Leukogene Therapeutics Inc. introduces a promising therapy to treat multiple cancers and hopes to become flagship entity for MUSC’s innovation ecosystem.

The new Elekta Esprit Gamma Knife helps doctors to give patients with brain metastases more options.

A recent MUSC study found that hypertensive disorders of pregnancy may contribute to higher rates of blood clots in women years after delivery.

For people with HIV, the risk of anal cancer varies significantly depending on the region of the country where they live.

Teaching & Learning in Age of Artificial Intelligence conference underscores MUSC’s role as leader in health sciences education, research, patient care.

MUSC’s ReJoyce Green, Ph.D., leads study highlighted in prestigious publication showing which factors may predict substance use in adolescents.

A lung cancer diagnosis has focused Laura Reed's mind on how she wants to live her life.

After bladder cancer diagnosis, writer tells doctor: "I am going to live to 115. I have books to write."

Renovation for innovation: Blue Sky building on Calhoun to house lab and collaboration space and serve as launch of innovation district.